Acutaas Chemicals Limited
Quick Take
- • Trading at 70.4× trailing earnings (47.0× forward)
- • Strong ROE at 23.4%
- • Low leverage (D/E 0.02)
- • Modest dividend yield of 0.08%
- • Operating margin 31.3% · Net margin 26.4%
- • Profit growth +67.10% YoY · Beta 0.02
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 330 | -21.80% | +9.27% |
| Operating Profit | 115 | -40.72% | +26.37% |
| Net Profit | 74 | -43.94% | +19.35% |
| EPS (₹) | 9.04 | — | — |
Shareholding Pattern
| Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Promoters | 35.97% | 35.96% | 35.96% | 32.66% | 32.66% | 32.66% | 32.66% | 32.66% |
| FIIs▲2.13 | 13.87% | 15.52% | 16.48% | 16.94% | 16.85% | 16.67% | 19.48% | 21.61% |
| DIIs▼0.04 | 19.93% | 20.24% | 18.31% | 22.38% | 22.59% | 21.70% | 19.60% | 19.56% |
| Government | 0.00% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public▼2.08 | 30.23% | 28.27% | 29.23% | 28.01% | 27.89% | 28.96% | 28.24% | 26.16% |
| No. of Shareholders | 93,394 | 95,756 | 1,14,060 | 1,19,890 | 1,08,664 | 1,10,363 | 1,12,939 | 1,25,569 |
* 1. The Nomination & Remuneration Committee, at its meeting held on December 22, 2025, granted 3,25,009 stock options, each convertible into one equity share of face value Rs.5/- under the Ami Organics Employee Stock Option Scheme, 2023 (ESOS 2023). The options are scheduled to vest over a period of four anniversary years from the date of grant, subject to the terms and conditions of the Scheme. 2. During the quarter ended June 30, 2026, 13,636 unvested stock options lapsed due to resignation of employee (Option Grantee). Accordingly, the number of equity shares on fully diluted basis have be
| Date | Party | Type | Side | Qty | Price |
|---|---|---|---|---|---|
| 10 Mar 26 | Vijay Gosar | Insider · Employees/Designated Employees | Sell | 500 | ₹2,144.26 |
| 20 Feb 26 | Mehul Mansukhbhai Koladia | Insider · Employees/Designated Employees | Sell | 20,000 | ₹2,110.21 |
| 30 Dec 25 | Bhavesh Mansukhbhai Kotadiya | Insider · Employees/Designated Employees | Buy | 2,100 | ₹1,672.34 |
| 24 Nov 25 | Ishares Core Msci Emerging Markets Etf | Bulk deal | BUY | 5,30,290 | ₹1,852.12 |
About the company
From latest AR & concallAcutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients, as well as new chemical entities. It also provides specialty chemicals, including photoresist chemicals for semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.
